News

New data shows that almost 50% of people with blood cancer do not have detectable levels of antibodies able to neutralise the Omicron variant after a third vaccine dose.

A team led by Oxford academics has published a study that suggests robust and long-lasting protection is given by a single vaccine dose in people who have previously caught COVID-19.

A study undertaken by researchers at Edinburgh University has shown that unvaccinated women and their babies are much more likely to become very unwell with COVID-19 during pregnancy.

The Wellcome Trust has committed to increasing its charitable spending to £16 billion over the next decade to fund science that supports human health, including a focus on next-generation COVID-19 vaccines.

The 2022 New Year Honours list has recognised a number of researchers whose work has been vital to refining our understanding of how to tackle COVID-19 with vaccines.

A new national study will examine the immune response to COVID-19 vaccination in immunocompromised people.

Our Focus on… series uses recent COVID-19 vaccine research from UK scientists to shine a spotlight on areas of specific interest to researchers, policy makers and the public.

A vaccine that is delivered via a blast of air rather than a needle has entered safety trials in Southampton.

A study led by researchers at the University of Southampton has delivered promising early results for the world’s first plant-based vaccine against COVID-19.

New research suggests that elderly care home residents are more likely to have robust immune responses to COVID-19 vaccination if they have previously been infected with SARS-CoV-2.